Parkinson’s disease and Huntington’s disease are caused by the death of nerve cells in the part of the brain called basal ganglia.
Our goal is to develop and improve treatments for the diseases and to improve quality of life for patients and their families.
Once a diplomat frequenting war-torn corners of the world, France’s ambassador to Sweden now has quite a different set of challenges to meet. For example, integrating into Swedish social culture by navigating the do’s and don'ts of Friday fika. But Pierre LaCroix, a man with many strings to his bow, is also concerned with promoting French-Swedish scientific collaboration. On February 17th he visited Lund to get further insight into the neuroscientific research going on within the BMC walls.
The Patient Participation in Parkinson's event on February 4th brought together strong voices in the growing debate on the role of patients as partners in health care development. Two prominent patient advocates, Sara Riggare and Jon Stamford, were joined on stage by Marjan Faber of the Dutch organization ParkinsonNet and Peter Hagell, an expert in the field of patient-driven outcomes measurements. The concluding debate, live webcast online, triggered a broader discussion where engaged contributors took part via twitter and other social media.